Toxoplasmosis and allogeneic stem cell transplantation: Can we do better?

Leukemia and Lymphoma

Volumn 51, Issue 8, 2010, Pages 1395-1396

  Slavin, Monica A ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PROTOZOON ANTIBODY; RNA 18S;

ALLOGENEIC STEM CELL TRANSPLANTATION; BRAIN DAMAGE; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION RISK; NEUROIMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEROPREVALENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; SURVIVAL RATE; TOXOPLASMA; TOXOPLASMOSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77955435800     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.503822     Document Type: Note

References (11)

1. Cavattoni I, Ayuk F, Zabelina T, et al. Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplantation can be difficult and requires intensive scrutiny. Leuk Lymphoma 2010;51:1530-1535.
2. Derouin F, Pelloux H; ESCMID Study Group on Clinical Parasitology. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008;14:1089-1101.
3. Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. BoneMarrowTransplant 1994;13:549-557.
4. Mulanovich VE, Ahmed SI, Ozturk T, et al. Toxoplasmosis in allo-SCT patients: risk factors and outcomesat a transplantation center with a low incidence. Bone Marrow Transplantation advance online publication, 3 May 2010; doi:10.1038/bmt.2010.102.
5. Derouin F, Devergie A, Auber P, et al. Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin Infect Dis 1992;15:267-270.
6. Martino R, Bretagne S, Einsele H, et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005;40:67-78.
7. De Medeiros BC, de Medeiros CR, Werner B, et al. Disseminated toxoplasmosis after bone marrow transplantation: a report of 9 cases. Transpl Infect Dis 2001;3:24-28.
8. Matsuo Y, Takeishi S, Miyamoto T, et al. Toxoplasmosis encephalitis following severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: 17 year experience in Fukuoka BMR group. Eur J Haematol 2007; 79:317-321.
9. Menotti J, Vilela G, Romand S, et al. Comparison of PCRenzymelinked immunosorbent assay and real-time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient. J Clin Microbiol 2003;41: 5313-5316.
10. Fricker-Hidalgo H, Bulabois CE, Brenier-Pinchart MP, et al. Diagnosis of Toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin Infect Dis 2009;48:e9-e15.
11. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009;15:1143-1238.